e-learning
resources
London 2016
Monday, 05.09.2016
Basic science and case reports in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: The role of eosinophils in Kras-G12D induced lung tumor initiation and progression
Fei Li (Hangzhou, China), Fei Li, Chao Zhang, Xufei Du, Man Luo, Chen Zhu, Songmin Ying, Zhihua Chen, Wen Li, Huahao Shen
Source:
International Congress 2016 – Basic science and case reports in lung cancer
Session:
Basic science and case reports in lung cancer
Session type:
Thematic Poster
Number:
2843
Disease area:
Airway diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fei Li (Hangzhou, China), Fei Li, Chao Zhang, Xufei Du, Man Luo, Chen Zhu, Songmin Ying, Zhihua Chen, Wen Li, Huahao Shen. LATE-BREAKING ABSTRACT: The role of eosinophils in Kras-G12D induced lung tumor initiation and progression. Eur Respir J 2016; 48: Suppl. 60, 2843
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
IL-17C promotes tumor-associated inflammation and lung tumor growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
COPD-like inflammation drives the progression of K-ras induced early cancerous lesions
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
LATE-BREAKING ABSTRACT: Expression of macrophage migration inhibitory factor (MIF) in the serum and lung tissues in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer?
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017
Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
LATE-BREAKING ABSTRACT: Osteopontin as an airway epithelial tumor promoter
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
The role of Pten in the cell-fate determination of epithelial cells in lung development
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Investigate which PKC isoform play an important role in human lung cancer cells against TRAIL-induced apoptosis
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
LATE-BREAKING ABSTRACT: Lung tumor cell migration and metastasis formation is conversely regulated by transmembrane and cytoplasmic syndecan-1 cleavage fragments
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Role of dendritic cell subsets in the early stage of cigarette smoke-induced lung inflammation
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
CD33
+
CD14
-
CD11b
+
CD66b
+
CD15
+
VEGFR-1
hi
myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept